Botulinum toxin in the treatment of facial paralysis: a minimally invasive rehabilitation treatment

Authors

DOI:

https://doi.org/10.33448/rsd-v10i5.15204

Keywords:

Facial asymmetry; Facial nerve; Facial paralysis; Botulinum toxin type A.

Abstract

Botulinum toxin is attained through an anaerobic bacteria known as Clostridium botulinum and can be used for several purposes, from aesthetic purposes to the treatment of various diseases, such as in the rehabilitation of patients with facial paralysis. The aim of the present work is to show the importance and the effects of the application of botulinum toxin in patients with facial paralysis, as well as to analyze the indications and clinical applicability of the product. Researches were carried out from databases such as Google Scholar, Lilacs, Scielo, preferably between the period of 2000 and 2020, by searching for the following keywords: “Facial Paralysis”, “Botulinum toxin”, “Facial symmetry”, in which articles were selected with complete texts, written in Portuguese and in English. The use of botulinum toxin in the rehabilitation of patients with facial paralysis is raising more and more, and studies on the product are growing in order to achieve a single use protocol, even though it's still noticeable the lackness of these studies. The rehabilitation of patients with facial paralysis who use botulinum toxin is effective and safe, and it can be na option to improve facial asymmetry.

References

Abboud, W. A., Hassin-Baer, S., Joachim, M., Givol, N., & Yahalom, R. (2017). Localized myofascial pain responds better than referring myofascial pain to botulinum toxin injections. Int J Oral Maxillofac Surg, 46(11), 1417-1423.

Barbero, P., Busso, M., Artusi, C. A., De Mercanti, S., Tinivella, M., Veltri, A. et al. (2016). Ultrasound-guided Botulinum Toxin-A Injections: a method of treating sialorrhea. J Vis Exp, 9(117), 54606.

Bento, R. F., Brito, R. V. (2004). Gunshot wounds to the facial nerve. Otol Neurotol, 25(6), 1009-1013.

Bernardes, D. F. F., Gomez, M. V. S. G., Pirana, S., & Bento, R. F. (2004). Functional profile in patients with facial paralysis treated in a myofunctional approach. Pro Fono, 16(2), 151-158.

Brennan, A., & Hickey, M. (2019). Botulinum toxin in women’s health: an update. Maturitas, 119(1), 21-24.

Carruthers, A. (2003). History of the clinical use of botulinum toxin A and B. Clin Dermatol, 21(6), 469–472.

Choe, W. J., Kim, H. D., Han, B. H., & Kim, J. (2017). Thread lifting: a minimally invasive surgical technique for long-standing facial paralysis. HNO, 65(11), 910-915.

Choo, P. H., Carter, S. R., & Seiff, S. R. (2000). Upper eyelid gold weight implantation in the Asian patient with facial paralysis. Plast Reconstr Surg, 105(3), 855-859.

Colhado, O. C. G., Boeing, M., & Ortega, L. B. (2009). Toxina botulínica no tratamento da dor. Rev Bras Anestesiol, 59(3), 366-381.

Cooper, L., Lui, M., & Nduka, C. (2017). Botulinum toxin treatment for facial palsy: a systematic review. J Plast Reconstr Aesthet Surg, 70(6), 833-841.

Cunha, M. C., Aguirrei, O. P., & Dias, C. R. S. (1998). Tratamento do espasmo facial unilateral com toxina botulínica tipo A. Arq Bras Oftal, 61(1), 54-60.

Dall'Magro, A. K., Santos, R., Dall’Magro, E., Fior, B., Matiello, C. N., & Carli, J. P. (2015). Aplicações da toxina botulínica em odontologia. Rev Salusvita, 34(2), 371-382.

Domingos, M. M. (2006). O uso da toxina botulínica em doentes com hipercinesia muscular facial contralateral à paralisia facial. Tese de Doutorado em Ciência, Universidade de São Paulo, São Paulo.

Dressler, D., Saberi, F. A., & Barbosa, E. R. (2005). Botulinum toxin: mechanisms of action. Arq Neuro psiquiatr, 63(1), 180-185.

Finn, J. C. (2004). Botulinum toxin type A: fine-tuning treatment of facial nerve injury. J Drugs Dermatol, 3(2), 133-137.

Freitas, K. C. S., & Gómez, M. V. G. (2008). Grau de percepção e incômodo quanto à condição facial em indivíduos com paralisia facial periférica na fase de seqüelas. Rev Soc Bras Fonoaudiol, 13(2), 113-118.

Freund, B., & Schwartz, M. (2003). Temporal relationship of muscle weakness and pain reduction in subjects treated with botulinum toxin A. J Pain, 4(3), 159-165.

Garanhani, M. R., Cardoso, J. R., Capelli, A. M. G., & Ribeiro, M. C. (2007). Fisioterapia na paralisia facial periférica: estudo retrospectivo. Rev Bras Otorrinolaringol, 73(1), 112-115.

Jinnah, H. A., & Factor, S. A. (2015). Diagnosis and treatment of dystonia. Neurol Clin, 33(1), 77-100.

Lobbezoo, F., Ahlberg, J., Raphael, K. G., Wetselaar, P., Glaros, A. G., Kato, T. et al. (2018). Consenso internacional sobre a avaliação do bruxismo: relatório de um trabalho em andamento. J Oral Rehabil, 45(11), 837-844.

Maio, M., & Soares, M. F. D. (2007). Toxina Botulínica em Paralisia Facial: um tratamento miminamente invasivo para redução da hipercinesia muscular da região perioral contralateral. Arq Int Otorrinolaringol, 11(1), 28-35.

Marciano, A., Aguiar, U., Vieira, P. G. M., & Magalhães, S. R. (2014). Toxina botulínica e sua aplicação na odontologia. Rev Iniciaç Cient Universidade Vale Rio Verde, 4(1), 65-75.

Martins, R. R., Silveira, A. M. M., Neto, J. S. R., Martins, J. C. G., & Pessoa, C. V. (2017). Toxina botulínica tipo A no tratamento de rugas: uma revisão de literatura. Mostr Cient Farm, 3(1). http://publicacoesacademicas.unicatolicaquixada.edu.br/index.php/mostracientificafarmacia/article/view/1271/1038

Mejia, N. I., Vuong, K. D., & Jankovic, J. (2005). Long-term botulinum toxin efficacy, safety and immunogenicity. Mov Disord, 20(5), 592-597.

Motz, K. M., & Kim, Y. J. (2016). Auriculotemporal Syndrome (Frey Syndrome). Otolaryngol Clin North Am, 49(2), 501–509.

Neuenschwander, M. C., Pribitkin, E. A., & Sataloff, R. T. (2000). Botulinum toxin in otolaryngology: a review of its actions and opportunities for use. Ear Nose Throat J, 79(10), 788-789.

Oztel, M., Bilski, W. M., & Bilski, A. (2017). Botulinum toxin used to treat recurrent dislocation of the temporomandibular joint in a patient with osteoporosis. Br J Oral Maxillofac Surg, 55(1), e1-e2.

Park, J., & Park, H. J. (2017). Botulinum Toxin for the Treatment of Neuropathic Pain. Toxins, 9(9), 260-275.

Pereira, A., Shitsuka, D. M., Parreira, F. J., & Shitsuka, R. (2018). Metodologia da Pesquisa Científica. Santa Maria/RS. 1. Ed. UAB/NTE/UFSM. https://repositorio.ufsm.br/bitstream/handle/1/15824/Lic_Computacao_Metodologia-Pesquisa-Cientifica.pdf?sequence=1

Prechel, U., Ottl, P., Ahlers, O. M., & Neff, A. (2018). The Treatment of Temporomandibular Joint Dislocation. Dtsch Arztebl Int, 115(5), 59-64.

Salles, A. G. (2006). Avaliação do efeito da toxina botulínica no lado são em pacientes com paralisia facial de longa duração. Tese de Doutorado em Ciência, Universidade de São Paulo, São Paulo.

Scott, A. B. (1980). Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology, 87(10), 1044-1049.

Serrera-Figallo, M. A., Ruiz‐de‐León‐Hernández, G., Torres‐Lagares, D., Castro‐Araya, A., Torres‐Ferrerosa, O., Hernández‐Pacheco, E. et al. (2020). Use of Botulinum Toxin in Orofacial Clinical Practice. Toxins, 12(2), 1-16.

Shumrick, K. A., & Pensak, M. L. (2000). Early perioperative use of polytef suspension for the management of facial paralysis after extirpative skull base surgery. Arch Facial Plast Surg, 2(4), 243-248.

Steffen, A., Hasselbacher, K., Heinrichs, S., & Wollenberg, B. (2014). Botulinum toxin for salivary disorders in the treatment of head and neck cancer. Anticancer Res, 34(11), 6627-6632.

Sundaram, H., Signorini, M., Liew, S., Almeida, A. R. T., Wu, Y., Braz, A. V. et al. (2016). Consenso Global de Estética: toxina botulínica tipo A - revisão baseada em evidências, conceitos emergentes e recomendações de consenso para uso estético, incluindo atualizações sobre complicações. Plast Reconstr Surg, 137(3), 518e-529e.

Thomas, N. J., & Aronovich, S. (2017). Does Adjunctive Botulinum Toxin A Reduce Pain Scores When Combined With Temporomandibular Joint Arthroscopy for the Treatment of Concomitant Temporomandibular Joint Arthralgia and Myofascial Pain?. J Oral Maxillofac Surg, 75(12), 2521-2528.

Ueda, K., Harii, K., Asato, H., Yoshimura, K., & Yamada, A. (1999). Evaluation of muscle graft using facial nerve on the affected side as a motor source in the treatment of facial paralysis. Scand J Plast Reconstr Surg Hand Surg, 33(1), 47-57.

Unno, E. K., Sakata, R. K., & Issy, A. M. (2005). Estudo comparativo entre toxina botulínica e bupivacaína para infiltração de pontos-gatilho em síndrome dolorosa miofascial crônica. Rev Bras Anestesiol, 55(2), 250-255.

Xiao, L., Pan, Y., Zhang, X., Hu, Y., Cai, L., Nie, Z. et al. (2016). Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment. Neurol Sci, 37(11), 1807-1813.

Yuksel, B., Genc, F., Yaman, A., Goksu, E. O., Ak, P. D., & Gomceli, Y. B. (2019). Evaluation of stigmatization in hemifacial spasm and quality of life before and after botulinum toxin treatment. Acta Neurologica Belgica, 119(1), 55-60.

Published

11/05/2021

How to Cite

ÊNIA, J. R. N. .; FERNANDES, J. G. de A. .; NASCIMENTO, F. .; SILVA, L. de A. M. .; REIS, T.; DIETRICH, L. . Botulinum toxin in the treatment of facial paralysis: a minimally invasive rehabilitation treatment. Research, Society and Development, [S. l.], v. 10, n. 5, p. e40510515204, 2021. DOI: 10.33448/rsd-v10i5.15204. Disponível em: https://www.rsdjournal.org/index.php/rsd/article/view/15204. Acesso em: 6 dec. 2022.

Issue

Section

Review Article